These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 488544

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps.
    Pietri A, Ehle AL, Raskin P.
    Diabetes; 1980 Aug; 29(8):668-71. PubMed ID: 7002680
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes.
    Yamamoto T, Raskin P, Aydin I, Unger R.
    Metabolism; 1979 May; 28(5):568-74. PubMed ID: 449698
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Continuous intravenous insulin therapy with a miniaturized open-loop system.
    Renner R, Hepp KD, Mehnert H, Franetzki M.
    Horm Metab Res Suppl; 1979 May; (8):186-90. PubMed ID: 395077
    [Abstract] [Full Text] [Related]

  • 8. D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics.
    Neuhaus C, Kerner W, Maier V, Pfeiffer EF.
    Horm Metab Res Suppl; 1979 May; (8):115-8. PubMed ID: 395066
    [Abstract] [Full Text] [Related]

  • 9. Preprogrammed insulin infusion with a portable pump system.
    Irsigler K, Kritz H, Kaspar L, Brändle J, Koller W, Franetzki M.
    Horm Metab Res Suppl; 1979 May; (8):193-7. PubMed ID: 119699
    [Abstract] [Full Text] [Related]

  • 10. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L, Sherwin R, Hendler R, Felig P.
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [Abstract] [Full Text] [Related]

  • 11. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
    Schock A, Schultz M, Kerner W, Maier V, Pfeiffer EF.
    Horm Metab Res Suppl; 1979 May; (8):93-6. PubMed ID: 395097
    [Abstract] [Full Text] [Related]

  • 12. Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.
    Villaume C, Beck B, Kolopp M, Toussain P, Debry G.
    Biomed Pharmacother; 1986 May; 40(2):61-4. PubMed ID: 2875745
    [Abstract] [Full Text] [Related]

  • 13. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.
    Oskarsson PR, Lins PE, Backman L, Adamson UC.
    Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326
    [Abstract] [Full Text] [Related]

  • 14. Defective glucose counterregulation limits intensive therapy of diabetes mellitus.
    Santiago JV, White NH, Skor DA, Levandoski LA, Bier DM, Cryer PE.
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E215-20. PubMed ID: 6380308
    [Abstract] [Full Text] [Related]

  • 15. Effect of insulin therapy on the profiles of plasma immunoreactive glucagon in juvenile-type and adult-type diabetics.
    Raskin P, Unger RH.
    Diabetes; 1978 Apr; 27(4):411-9. PubMed ID: 640246
    [No Abstract] [Full Text] [Related]

  • 16. The external artificial pancreas: an instrument to induce remissions in severe recent juvenile diabetes. Comparison with a preprogrammed insulin infusion system.
    Mirouze J, Selam JL, Pham TC, Orsetti A.
    Horm Metab Res Suppl; 1979 Apr; (8):141-5. PubMed ID: 395071
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transient diabetes mellitus in a neonate. Evaluation of insulin, glucagon, and growth hormone secretion and management with a continuous low-dose insulin infusion.
    Sodoyez-Goffaux F, Sodoyez JC.
    J Pediatr; 1977 Sep; 91(3):395-9. PubMed ID: 894407
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels.
    Paolisso G, Sgambato S, Passariello N, Scheen A, D'Onofrio F, Lefèbvre PJ.
    Diabetes; 1987 May; 36(5):566-70. PubMed ID: 2883055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.